SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore.

Dina SweedEman AbdelsameeaEsraa A KhalifaHeba AbdallahHeba MoazInas MoazShimaa AbdelsattarNadine Abdel-RahmanAsmaa MosbehHussein A ElmahdyEman Sweed

Published in: Egyptian liver journal (2021)

GI manifestations are common in COVID-19 patients. Special care should be paid for high-risk patients, older males, and those with background liver disease.

Keyphrases

sars cov
end stage renal disease
chronic kidney disease
healthcare
ejection fraction
newly diagnosed
palliative care
peritoneal dialysis
prognostic factors
respiratory syndrome coronavirus
quality improvement
pain management
coronavirus disease
chronic pain
health insurance